A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities

Clinical trial NCT05872269 · UNKNOWN

Trial details

NCT number: NCT05872269
Sponsor: Zydus Lifesciences Limited
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

NAFLD Obesity Type 2 Diabetes Dyslipidemias Metabolic Syndrome

Start date: 2023-07-20
Primary completion: 2025-01-10
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.